Alvimopan provides additional improvement in outcomes and cost savings in enhanced recovery colorectal surgery

Mohamed Abdelgadir Adam, Lacey M. Lee, Jina Kim, Mithun Shenoi, Mohan Mallipeddi, Hamza Aziz, Sandra Stinnett, Zhifei Sun, Christopher R. Mantyh, Julie K.M. Thacker

Research output: Contribution to journalArticlepeer-review

Abstract

Objective: To examine the impact of alvimopan on outcomes and costs in a rigorous enhanced recovery colorectal surgery protocol. Background: Postoperative ileus remains a major source of morbidity and costs in colorectal surgery. Alvimopan has been shown to reduce incidence of postoperative ileus in enhanced recovery colorectal surgery; however, data are equivocal regarding its benefit in reducing length of stay and costs. Methods: Patients undergoing major elective enhanced recovery colorectal surgery were identified from a prospectively-collected database (2010-2013). Multivariable analyses were employed to compare outcomes and hospital costs among patients who had alvimopan versus no alvimopan by adjusting for demographic, clinical, and treatment characteristics. Results: A total of 660 patients were included; 197 patients received alvimopan and 463 patients had no alvimopan. In unadjusted analysis, the alvimopan group had a faster return of bowel function, shorter length of stay, and lower rates of ileus, Foley re-insertion, and urinary tract infection (all P<0.01). After adjustment, alvimopan was associated with a faster return of bowel function by 0.6 day (P=0.0006), and lower incidence of postoperative ileus (odds ratio 0.23, P=0.0002). With adjustment, alvimopan was associated with a shorter length of stay by 1.6 days (P=0.002), and a hospital cost savings of $1492 per patient (P=0.01). Conclusions: Alvimopan administration as an element of enhanced recovery colorectal surgery is associated with faster return of bowel function, lower incidence of postoperative ileus, shorter hospitalization, and a significant cost savings. These results suggest that alvimopan is cost-effective in the setting of enhanced recovery colorectal surgery protocols, and should therefore be considered in these programs.

Original languageEnglish (US)
Pages (from-to)141-146
Number of pages6
JournalAnnals of surgery
Volume264
Issue number1
DOIs
StatePublished - Jul 1 2016
Externally publishedYes

Keywords

  • alvimopan
  • colorectal surgery
  • enhanced recovery after surgery
  • entereg

ASJC Scopus subject areas

  • Surgery

Fingerprint Dive into the research topics of 'Alvimopan provides additional improvement in outcomes and cost savings in enhanced recovery colorectal surgery'. Together they form a unique fingerprint.

Cite this